BCG immunotherapy for recurrent malignant melanoma
- 1 January 1980
- journal article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 10 (1) , 17-26
- https://doi.org/10.1007/bf00199274
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Recall antigen delayed-type hypersensitivity skin testing: standardization of self-reading by patientsCancer Immunology, Immunotherapy, 1979
- IMMUNOTHERAPY OF HUMAN SOLID TUMORS WITH BACILLUS CALMETTE‐GUÉRIN: PROLONGATION OF DISEASE‐FREE INTERVAL AND SURVIVAL IN MALIGNANT MELANOMA, BREAST, AND COLORECTAL CANCER*Annals of the New York Academy of Sciences, 1976
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-GuérinNew England Journal of Medicine, 1974
- BCG stimulation of immune responsiveness in patients with malignant melanoma.Preliminary reportCancer, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958